Jamaica
+919359902383
+919359902383

sedative hypnotic

68179d65be22ee500d53ff54 Card 2

product image
sedative-hypnotic

Extensive Product Profile: Understanding Zopidaily 10 mg (Zopiclone) Zopidaily 10 mg contains zopiclone, a non-benzodiazepine hypnotic agent belonging to the cyclopyrrolone class. It is a potent sedative used for the short-term management of severe insomnia, helping patients initiate and maintain restorative sleep patterns. 1. Clinical Indications & Usage Severe Insomnia: Primarily used for the short-term relief of debilitating insomnia where difficulty falling asleep or frequent nighttime awakenings significantly impair daily functioning. Circadian Stabilization: Occasionally used to assist in resetting sleep-wake cycles disrupted by acute stress or temporary medical conditions. 2. Mechanism of Action GABA Receptor Modulation: It binds to the benzodiazepine binding site on the Inhibitory Enhancement: By modulating these receptors, Zopidaily increases the effect of Gamma-Aminobutyric Acid (GABA), the body’s primary inhibitory neurotransmitter. This activity reduces overall nerve activity in the brain, inducing a calming and sedative effect. Sleep Promotion: By effectively dampening overactive neuronal signals, it reduces sleep latency (time taken to fall asleep) and helps maintain consistent sleep, providing a more restorative rest cycle without significantly disrupting natural sleep architecture. 3. Administration and Dosing Guide Timing: Administer one tablet orally with water immediately before retiring to bed. It should only be taken when the patient has the opportunity to get a full 7–8 hours of uninterrupted sleep. Route: Zopidaily 10 mg is an oral tablet. Consistency: The tablet should be swallowed whole; do not crush, split, or chew the medication. Medical Supervision: The dosage should be strictly followed as prescribed. It is not intended for long-term continuous use. ⚠️ Safety, Side Effects, and Monitoring Daytime Sedation: Users may experience lingering drowsiness, impaired alertness, or reduced psychomotor coordination the following morning. Avoid driving, operating heavy machinery, or performing tasks requiring high mental focus until the effects have completely worn off. Withdrawal Risks: Abrupt discontinuation can lead to “rebound insomnia“ or withdrawal symptoms. Always consult a physician for a tapering plan. Common Side Effects: A characteristic metallic or bitter taste in the mouth (dysgeusia), dry mouth, headache, dizziness, and mild nausea. 📦 Storage and Handling Specifications Storage: Store in a cool, dry place, ideally below 25°C. Environment: Keep in original manufacturer packaging to protect from light and moisture. Safety: Keep strictly out of reach of children, domestic pets, and individuals prone to substance misuse. 📄 Regulatory and Compliance Documentation Authentic Certificate of Analysis (COA). Verified Batch Origin documentation. Relevant global import compliance paperwork. PRESCRIPTION MEDICINE IS : YES Clinical Disclaimer: Zopidaily 10 mg is a prescription-only medication. This profile is for educational purposes and is not a substitute for professional medical advice. Always consult with a licensed physician regarding its use. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com | www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Supplier | Distributor 📲 WhatsApp: +91 93599 02383 | Chat on WhatsApp

68179d65be22ee500d53ff54 Card 2

product image
sedative-hypnotic

Product Profile: Zopicol 7.5 mg Zopicol 7.5 mg contains Zopiclone, a non-benzodiazepine hypnotic agent from the cyclopyrrolone class. It is indicated for the short-term management of severe insomnia, helping patients achieve a more regular sleep pattern by inducing sleep and reducing the frequency of nighttime awakenings. 1. Clinical Indications & Usage Insomnia Management: Indicated for the short-term treatment of transient, situational, or chronic insomnia. Therapeutic Goal: Assists in shortening sleep onset latency and improving overall sleep maintenance in adults for whom insomnia is debilitating. 2. Mechanism of Action Zopicol acts as a central nervous system (CNS) depressant: GABA-A Receptor Modulation: It binds selectively to the GABA-A receptor complex, specifically the omega-1 receptor subtype. Sedative Effect: By enhancing the inhibitory effects of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain, Zopicol produces sedative, hypnotic, and anxiolytic effects, effectively calming neural activity to facilitate sleep. 3. Administration and Dosing Guide Administration: Take one tablet orally immediately before bedtime. Dosage: The recommended dose for adults is typically 7.5 mg. Due to the rapid onset of action, patients should ensure they have a full 7–8 hour window available for sleep before needing to be active. Duration: Therapy should be as short as possible, generally ranging from a few days to two weeks. Prolonged use is not recommended due to the potential for dependency and tolerance. ⚠️ Safety, Side Effects, and Monitoring Warnings: Zopicol can cause daytime drowsiness, dizziness, or impaired alertness. Avoid operating heavy machinery or driving after ingestion. Contraindications: Do not consume alcohol or other CNS depressants while using Zopicol, as this significantly increases the risk of respiratory depression and excessive sedation. Common Side Effects: A characteristic metallic or bitter taste in the mouth (dysgeusia), dry mouth, drowsiness, headache, and dizziness. Dependency Risk: Long-term use or abrupt discontinuation may lead to withdrawal symptoms or rebound insomnia. Tapering under medical supervision is often required. 📦 Storage, Stability & Commercial Packaging Storage Environment: Store in a cool, dry place (below 30°C/86°F). Protection: Maintain in original manufacturer’s blister packaging to protect from light and atmospheric moisture. Safety: Must be kept strictly out of the reach of children, as accidental ingestion can be dangerous. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Zopicol 7.5 mg is a prescription medicine and must be utilized solely under the direct guidance of a registered medical specialist. All cross-border importing setups must comply with the native health authorities of the destination country 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] Connect with our global trade desk for procurement inquiries, commercial documentation, and supply chain logistics: 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

68179d65be22ee500d53ff54 Card 2

product image
sedative-hypnotic

Eszopigard-3 mg Tablets: High-Potency Non-Benzodiazepine Hypnotic for Global Institutional Supply Chains In-Depth Product Analysis & Clinical Profile Eszopigard-3 mg Tablet is a highly specialized oral sleep-induction medication engineered for targeted clinical intervention in severe sleep architectural disruptions. Each tablet contains exactly 3 mg of Eszopiclone USP, a highly pure non-benzodiazepine hypnotic agent belonging to the cyclopyrrolone chemical class, recognized worldwide as a therapeutic standard for complex sleep maintenance disorders. Clinical Indications & Therapeutic Scope Severe Sleep Maintenance Insomnia: Specifically formulated for patients who experience frequent, abnormal nighttime awakenings, helping them achieve a continuous, deep, and stable sleep cycle throughout the night. Chronic and Transient Insomnia: Indicated to significantly reduce sleep onset latency (the total time taken to fall asleep) and extend total sleep duration in patients whose circadian rhythms have been disrupted by neurological imbalances, somatic stress, or situational trauma. Chronic and Transient Insomnia: Indicated to significantly reduce sleep onset latency (the total time taken to fall asleep) and extend total sleep duration in patients whose circadian rhythms have been disrupted by neurological imbalances, somatic stress, or situational trauma. Physiological Mechanism of Action Selective GABA-A Receptor Modulation: Eszopiclone functions as a highly selective positive allosteric modulator that binds to the gamma-aminobutyric acid- receptor complex. It targets specific receptor sub-units at a site distinct from traditional benzodiazepine molecules. Chloride Channel Amplification: By enhancing the affinity of the receptor for endogenous (the central nervous system's primary inhibitory neurotransmitter), it triggers a greater influx of chloride ions into the post-synaptic neurons. Neuronal Hyperpolarization and Sedation: This ion influx induces post-synaptic cellular hyperpolarization, slowing down overactive neuronal firing across the brain's arousal centers. This calms the central nervous system, promotes muscle relaxation, and establishes the ideal physiological state for deep, restorative sleep. Technical Storage, Stability, and Handling Protocols Temperature Restrictions: Store Eszopigard-3 mg Tablets at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F). Moisture & Ultraviolet Mitigation: Keep the tablets sealed within their original factory blister packaging or high-barrier commercial containers. Protect the cargo from high humidity, steam, or direct exposure to sunlight. Inventory Safety: Store in a locked, secure pharmaceutical repository suitable for controlled prescription medications, completely separated from standard retail products and out of reach of minors. Comprehensive Clinical Side Effects & Tolerability Dysgeusia (Taste Alteration): A unique and highly common side effect characterized by a sharp, unpleasant, bitter, or metallic taste in the mouth immediately upon waking. Dysgeusia (Taste Alteration): A unique and highly common side effect characterized by a sharp, unpleasant, bitter, or metallic taste in the mouth immediately upon waking. Gastrointestinal and Mucosal Effects: Potential reactions include distinct dry mouth (xerostomia), mild nausea, dyspepsia, and a minor increase in susceptibility to mild respiratory tract infections due to secondary mucosal drying. International Regulatory Documentation & Quality Portfolios Certificate of Analysis (COA): Comprehensive laboratory validation proving exact 3 mg active ingredient concentration per unit, batch uniformity, dissolution rates, and absolute chemical purity. Certificate of Origin (COO): Officially stamped documentation verifying that the formulation was produced in an authorized, certified Indian pharmaceutical manufacturing facility. Customs-Ready Trade Manifesting: Detailed packing slips, commercial invoices, dangerous goods or restricted substance transport declarations, and correct Harmonized System (HS) import codes to ensure efficient processing through international border networks. PRESCRIPTION MEDICINE IS YES Clinical Disclaimer: This product summary is compiled strictly for international wholesale distribution networks, and digital optimization indexing. Eszopigard-3 mg Tablets (Eszopiclone) are highly potent, restricted prescription medications that carry a risk of misuse and dependency. This drug must be administered exclusively under the direct guidance and clinical evaluation of a licensed physician or psychiatrist. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383

68179d65be22ee500d53ff54 Card 2

product image
sedative-hypnotic

Zopfresh-E 6 mg Tablets: Advanced Hypnotic & Sleep Maintenance Therapy for Global Supply Chains Detailed Product Overview & Clinical Profile Zopfresh-E 6 mg Tablet is a highly specialized oral sedative-hypnotic formulation engineered for the targeted management of severe sleep architectural disruptions. Each film-coated tablet delivers a precise 6mg dose of Eszopiclone, a highly pure non-benzodiazepine hypnotic agent that has become a global standard in clinical sleep medicine. Clinical Indications & Therapeutic Scope Sleep Onset Insomnia: Indicated for patients who experience extreme difficulty initiating sleep, helping to significantly decrease sleep latency (the time it takes to fall asleep). Sleep Maintenance Insomnia: Formulated to reduce frequent, abnormal nighttime awakenings, ensuring a continuous and deeper sleep cycle throughout the night. Transient and Chronic Insomnia Management: Used in short-term clinical protocols to restore standard circadian rhythms disrupted by acute environmental stress, psychological fatigue, or chronic neurological imbalances. Physiological Mechanism of Action Central Nervous System Sedation: This electrical stabilization dampens overactive neuronal firing across the brain's arousal centers, naturally calming the central nervous system to induce rapid relaxation, accelerate sleep onset, and promote prolonged sleep maintenance. GABA-A Receptor Modulation: Eszopiclone functions as a non-benzodiazepine cyclic agent that binds selectively to the gamma-aminobutyric acid receptor complex at a site distinct from traditional benzodiazepines. Amplified Hyperpolarization: By acting as a positive allosteric modulator, it enhances the inhibitory actions of endogenous This triggers an influx of chloride ions into the post-synaptic neurons, resulting in cellular hyperpolarization. Strict Storage, Stability, and Handling Protocols Environmental Controls: Store Zopfresh-E 6mg Tablets strictly within a controlled room temperature range between 15°C to 30°C (59°F to 86°F). Moisture and Light Mitigation: Keep the tablets sealed within their original moisture-resistant blister packs or factory-sealed containers. Protect the stock from high ambient humidity, steam, and prolonged exposure to direct sunlight. Dispensing Safety: Store securely in an independent, locked storage location appropriate for controlled prescription medications, completely out of reach of children and unauthorized individuals. Clinical Side Effects & Tolerability Profile Taste Disturbances: A very common and distinct side effect is a persistent unpleasant, bitter, or metallic taste in the mouth (dysgeusia) upon waking. Central Nervous System Residual Effects: Patients may experience daytime drowsiness, mild dizziness, headaches, lightheadedness, or a feeling of a “hangover“ effect, particularly if they do not dedicate a full 7 to 8 hours to sleep after administration. Gastrointestinal and Systemic Distress: Potential side effects include dry mouth (xerostomia), mild nausea, dyspepsia, and occasional episodes of viral infections or colds due to transient immune shifts. Documentation & International Customs Compliance Certificate of Analysis (COA): Verifying independent laboratory assay testing, confirming precise 6mg Eszopiclone chemical potency, mass uniformity, and zero contamination. Certificate of Origin (COO): Officially validating genuine production and export compliance within certified Indian pharmaceutical manufacturing ecosystems. Customs-Validated Shipping Manifests: Providing precise packing lists, transparent commercial invoices, proper dangerous goods or controlled-substance shipping documentation, and correct Harmonized System (HS) codes tailored for smooth import processing. PRESCRIPTION MEDICINE IS YES Clinical Disclaimer: This comprehensive product profile is prepared for international wholesale distribution networks, and digital optimization indexing. Zopfresh-E 6 mg Tablet (Eszopiclone) is a highly potent, restricted prescription medication that can be habit-forming. It must be administered exclusively under the direct guidance and evaluation of a licensed physician or psychiatrist. It is strictly contraindicated for individuals with a history of complex sleep behaviors, severe respiratory depression, or advanced hepatic impairment. Patients must secure a dedicated 7 to 8 hours of uninterrupted sleep after consumption and must absolutely avoid alcohol or concurrent central nervous system depressants, 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

68179d65be22ee500d53ff54 Card 2

product image
sedative-hypnotic

Zopimaxx 20mg Tablet: High-Potency Non-Benzodiazepine Hypnotic for Advanced Insomnia & Sleep Maintenance Management Extensive Product Profile: In-Depth Insights on Zopimaxx 20mg Tablets Zopimaxx 20mg Tablet, manufactured under high-grade quality compliance systems within India, is a highly potent oral central nervous system (CNS) depressant. Each film-coated tablet features Zopiclone ($20text{ mg}$) as its active pharmaceutical ingredient. Zopiclone belongs to the cyclopyrrolone chemical class, functioning as a non-benzodiazepine hypnotic. It is engineered specifically to yield shorter sleep onset latency, decrease nocturnal awakenings, and improve overall sleep structure for patients enduring acute, debilitating sleep cycle disruptions. 1. Clinical Indications & Target Therapeutic Applications Severe, Disabling Insomnia: Indicated for the short-term management of acute or transient insomnia in adult patients who suffer from extreme sleep onset difficulties, frequent middle-of-the-night awakenings, or unrefreshing sleep. Psychiatric-Linked Sleep Disturbance: Utilized alongside primary treatments to quickly correct severe insomnia secondary to underlying mood disruptions, where chronic sleep debt severely impairs daylight cognitive and occupational functioning. 2. Comprehensive Mechanism of Action (MOA) Allosteric Modulation of $text{GABA}_text{A}$ Receptors: Unlike classic benzodiazepines that bind broadly across multiple receptor structures, Zopiclone acts with high affinity on specific sub-units of the Gamma-Aminobutyric Acid type A ($text{GABA}_text{A}$) macromolecular receptor complex in the brain. Chloride Channel Polarization: This selective binding structurally reinforces the affinity of the receptor for endogenous GABA, an inhibitory neurotransmitter. This action forces open the chloride ion channels, causing an influx of chloride ions that hyperpolarizes the postsynaptic neuronal membrane. 3. Storage, Stability, and Handling Protocols Environmental Matrix: Store Zopimaxx 20mg Tablets in their original moisture-tight blister cards or high-density containers at controlled room temperature, strictly between 15°C to 30°C (59°F to 86°F). Protect the stock from high ambient steam, humidity, and direct exposure to light. Administration Matrix: The tablet must be swallowed completely whole with water immediately before retiring to bed, or when the patient can guarantee a full 7 to 8 hours of undisturbed sleep. Never crush, chew, split, or dissolve the tablet matrix, as doing so disrupts targeted metabolic release patterns. Potential Side Effects of Zopimaxx 20mg Gastrointestinal Dysgeusia: A highly characteristic, persistent bitter or metallic taste in the mouth, frequently accompanied by dry mouth (xerostomia) and mild morning nausea. Residual Next-Day Sedation: Lingering daytime drowsiness, motor coordination impairment, dizziness, and mild cognitive slowing—particularly if the patient awakens before a full 8-hour sleep cycle. Export Documentation & Global Trade Compliance Certificate of Analysis (COA): Providing verifiable batch testing confirming the precise $20text{ mg}$ Zopiclone strength, active ingredient dissolution profiles, and chemical purity indices. Certificate of Origin (COO): Authenticating true manufacturing provenance within registered Indian production lines. Customs-Compliant Manifesting: Precision shipping manifests, clean packing lists, and commercial invoicing marked with correct global harmonized system (HS) codes for seamless clearance. PRESCRIPTION MEDICINE IS YES Disclaimer: This structural product review is prepared strictly for international business-to-business (B2B) trade procurement, wholesale distribution networks, and digital optimization indexing. Zopimaxx 20mg (Zopiclone) is a highly restricted, high-potency prescription hypnotic medication with distinct habit-forming potential. It must be prescribed and dispensed exclusively under licensed medical authority and in compliance with regional controlled substance regulations. It must never be taken with alcohol or concurrent central nervous system depressants. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.ernestimpex.com www.ernestvision.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Phone Number

+919359902383

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Kingston, Jamaica

Jamaica, Jamaica, 1